Who is the featured lecturer at the JPI seminar?

The featured lecturer is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare.

When and at what time is this seminar scheduled to be held?

The seminar is scheduled to take place on Thursday, April 9, 2026, from 09:30 to 11:30.

What is the main definition of the drug loss problem mentioned in the text?

The drug loss problem refers to pharmaceuticals that are approved in the West but not developed in Japan.

What are the three goals that the public and private sectors are working together to achieve?

The public and private sectors aim to strengthen Japan's drug discovery capabilities, deliver the latest medicines to citizens rapidly, and sustain a cycle of investment and innovation.

What are the main topics included in the agenda of the lecture?

The agenda includes the current status of drug loss, policies for building a drug discovery ecosystem, the status of clinical trials, MHLW initiatives, a Q&A session, and a business card exchange.

AI News NQ Analysis

[JPI Seminar] MHLW: "Building a Drug Discovery Ecosystem and Promoting Clinical Trials" to be held on Thursday, April 9

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: Who is the featured lecturer at the JPI seminar?: A: The featured lecturer is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare.
Q: When and at what time is this seminar scheduled to be held?: A: The seminar is scheduled to take place on Thursday, April 9, 2026, from 09:30 to 11:30.
Q: What is the main definition of the drug loss problem mentioned in the text?: A: The drug loss problem refers to pharmaceuticals that are approved in the West but not developed in Japan.
Q: What are the three goals that the public and private sectors are working together to achieve?: A: The public and private sectors aim to strengthen Japan's drug discovery capabilities, deliver the latest medicines to citizens rapidly, and sustain a cycle of investment and innovation.
Q: What are the main topics included in the agenda of the lecture?: A: The agenda includes the current status of drug loss, policies for building a drug discovery ecosystem, the status of clinical trials, MHLW initiatives, a Q&A session, and a business card exchange.